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Calmodulin (CaM) is the primary calcium signaling protein in eukaryotes and
has been extensively studied using various biophysical techniques. Prior crystal
structures have noted the presence of ambiguous electron density in both
hydrophobic binding pockets of Ca2+-CaM, but no assignment of these features
has been made. In addition, Ca2+-CaM samples many conformational substates
in the crystal and accurately modeling the full range of this functionally
important disorder is challenging. In order to characterize these features in
a minimally biased manner, a 1.0 A˚ resolution single-wavelength anomalous
diffraction data set was measured for selenomethionine-substituted Ca2+-CaM.
Density-modified electron-density maps enabled the accurate assignment of
Ca2+-CaM main-chain and side-chain disorder. These experimental maps also
substantiate complex disorder models that were automatically built using low-
contour features of model-phased electron density. Furthermore, experimental
electron-density maps reveal that 2-methyl-2,4-pentanediol (MPD) is present in
the C-terminal domain, mediates a lattice contact between N-terminal domains
and may occupy the N-terminal binding pocket. The majority of the crystal
structures of target-free Ca2+-CaM have been derived from crystals grown using
MPD as a precipitant, and thus MPD is likely to be bound in functionally critical
regions of Ca2+-CaM in most of these structures. The adventitious binding of
MPD helps to explain differences between the Ca2+-CaM crystal and solution
structures and is likely to favor more open conformations of the EF-hands in the
crystal.
1. Introduction
Calmodulin (CaM) is a highly conserved eukaryotic protein
that binds to Ca2+ and regulates the activities of hundreds
of downstream binding partners. CaM contains two similar
domains, each of which comprises two EF-hand Ca2+-binding
motifs (Babu et al., 1985). These two domains are separated
by a flexible linker region that allows the large interdomain
mobility needed for CaM to interact with its structurally
diverse targets (Ikura, Clore et al., 1992; Meador et al., 1992).
Upon binding Ca2+, the EF-hand helices in each of the two
domains of CaM sample more open conformations and expose
clusters of predominantly hydrophobic residues with an
unusually high surface density of phenylalanine and methio-
nine (Kuboniwa et al., 1995; O’Neil & Degrado, 1990). These
flexible hydrophobic pockets are then poised to interact with
protein targets in a variety of interaction modes that have
been structurally characterized over the past two decades
(Franco-Echevarrı´a et al., 2014; Lau et al., 2012; Sarhan et al.,
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2012; Fallon et al., 2009; Meador et al., 1992, 1993; Yamauchi et
al., 2003).
Because of its physiological importance, small size (148
amino acids), multidomain architecture and extensive
conformational dynamics, CaM has been widely studied using
a variety of structural and biophysical techniques. Both
solution NMR spectroscopy and X-ray crystallography have
demonstrated that CaM is highly flexible, particularly in
the central linker region comprising residues 70–90 (Ikura,
Barbato et al., 1992; Meador et al., 1993). Despite general
agreement about its structure, NMR and X-ray crystallo-
graphy have provided differing views of several important
details of Ca2+-CaM. For example, the central linker region is
helical in triclinic crystal structures of Ca2+-CaM (Babu et al.,
1988; Chattopadhyaya et al., 1992), but NMR spectroscopy
and crystal structures in other space groups have shown that
the linker is nonhelical from residues 78 to 81 (Fallon &
Quiocho, 2003; Ikura, Barbato et al., 1992). In addition, an
NMR spectroscopic study using residual dipolar coupling
information showed that both domains of Ca2+-CaM are more
closed in solution than in most crystal structures, particularly
in the N-terminal domain (Chou et al., 2001). Fundamentally,
these differences provide strong evidence for the highly
dynamic character of Ca2+-CaM; however, a more specific
explanation for these disparities is desirable. Of particular
interest is why the EF-hands in the triclinic crystal structure
of Ca2+-CaM are more open than they are in solution. While
crystal lattice artefacts are often invoked to explain the
continuous central helix region observed in triclinic Ca2+-
CaM, the more open EF-hands in each domain are not as
easily rationalized using crystal-packing arguments.
Previously, we determined an atomic resolution (1.0 A˚)
X-ray crystal structure of Ca2+-CaM from Paramecium tetra-
urelia (PDB entry 1exr; Wilson & Brunger, 2000). The high
resolution of this data set allowed the detailed characteriza-
tion of side-chain and backbone atomic disorder on multiple
length scales, providing evidence for widespread spatially
correlated disorder in the protein. However, several features
in those electron-density maps remained ambiguous, including
the prominent difference electron density located in both
hydrophobic binding pockets (Wilson & Brunger, 2000).
These features were mentioned in the original publication but
were left unmodeled owing to uncertainty in their proper
assignment. Similar electron-density features have been
described in other triclinic Ca2+-CaM structures (Chatto-
padhyaya et al., 1992), but no adequate explanation for them
has been provided. Because these unexplained electron-
density features are located in functionally critical regions of
Ca2+-CaM, it is important to convincingly assign them to a
molecular species.
To examine these ambiguous electron-density features with
minimal structural model phase bias, we collected a 1.0 A˚
resolution single-wavelength anomalous diffraction (SAD)
data set from Ca2+-SeMet CaM. Combined with modern
density-modification procedures, the experimental phases
produced an electron-density map of comparable quality to
the 2mFo  DFc electron density calculated from the final
refined model. The experimentally phased electron-density
map significantly reduced the ambiguity in the assignment of
correlated main-chain and side-chain disorder in Ca2+-CaM.
In addition, this experimental phase information confirms that
2-methyl-2,4-pentanediol (MPD) molecules are located in
the C-terminal binding pocket and mediate a crystal-packing
contact between adjacent N-terminal domains in the lattice.
Electron density in the N-terminal binding pocket is highly
suggestive of another bound MPD. MPD has been used at
50%(v/v) concentration as a precipitant in all prior triclinic
Ca2+-CaM structures; therefore, its binding to these regions of
the protein offers a potentially general explanation for the
more open EF-hands of the triclinic Ca2+-CaM crystal struc-
ture.
2. Methods
2.1. Protein expression, purification and crystallization
P. tetraurelia CaM was expressed using the previously
described pKK233-3 expression construct (Wilson & Brunger,
2000). Selenomethionine (SeMet) was incorporated using the
Escherichia coli methionine-auxotroph strain B834 grown in
M9 defined medium containing 1% glucose, 50 mg l1 of each
amino acid except methionine and cysteine, 7.5 mg l1 FeSO4
and 50 mg l1 l-SeMet. Protein expression and purification
were performed as described previously (Wilson & Brunger,
2000).
The purified and lyophilized SeMet CaM protein was
resuspended at 15 mg ml1 in 5 mM CaCl2, 50 mM sodium
cacodylate pH 5.0 and crystallized using the hanging-drop
vapor-equilibration method. A drop consisting of 4 ml
15 mg ml1 SeMet CaM in buffer was mixed with 1 ml
2-methyl-2,4 pentanediol (MPD). The drop was equilibrated
against a 1 ml reservoir consisting of 50 mM sodium cacody-
late pH 5.0, 50% MPD at 4C. Crystals of the native protein
were used for initial microseeding of SeMet CaM crystals
using a cat whisker. Subsequent microseeding was performed
using SeMet CaM crystals to ensure a uniform population of
SeMet-substituted protein.
Ca2+-SeMet CaM crystals grew in 2–5 d and reached
dimensions of 0.7  0.4  0.1 mm. The crystals were blade-
shaped and were mounted in nylon loops such that the longest
crystal axis was not collinear with the pin. The 50% concen-
tration of MPD in the mother liquor is sufficient to cryoprotect
the crystals, which were removed from the drop and immersed
into liquid propane held at its melting point in a liquid-
nitrogen bath.
2.2. Data collection and processing
SAD data were collected on beamline 9-1 at the Stanford
Synchrotron Radiation Laboratory (SSRL) from a single
crystal maintained at 100 K. The crystal was illuminated with
12 670 eV incident X-rays (0.9785 A˚) and data were measured
using a MAR345 image-plate detector with 150 mm pixel size.
The X-ray energy is 10 eV higher than the peak of
the measured Se X-ray fluorescence in similar crystals of
research papers
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Ca2+-SeMet CaM. Data were collected in inverse-beam
geometry with 20 wedges in both high-resolution and low-
resolution passes to avoid overloaded reflections. In order to
collect data in the blind cone, a second high-resolution pass
was measured from the crystal after reorientation. Diffraction
data were indexed, integrated and scaled in HKL-2000
(Otwinowski & Minor, 1997). Merging statistics, anomalous
signal and resolution limit were independently analysed using
the unmerged, integrated data with AIMLESS (Evans &
Murshudov, 2013) as implemented in the CCP4 suite (Winn et
al., 2011). Final data statistics are provided in Table 1.
2.3. SAD phasing and density modification
Anomalously scattering atoms were located using
SHELXC/D (Sheldrick, 2008), compared with the anomalous
difference Fourier maps calculated using model phases from
PDB entry 1exr and moved to a common origin to facilitate
comparison with the previously solved structure. These 12
heavy-atom sites were input into Phaser for SAD phasing
against the full data set extending to 1.0 A˚ resolution (Read &
McCoy, 2011). The overall figure of merit for the final SAD
phases was 0.44.
Density modification was performed using default settings
in RESOLVE as implemented in PHENIX (Terwilliger, 2004),
SOLOMON (Abrahams & Leslie, 1996), Pirate (Cowtan,
2000), DM (Cowtan et al., 2001) and Parrot (Cowtan, 2010)
in the CCP4 suite (Winn et al., 2011). Importantly, we used
Hendrickson–Lattman coefficients for the anomalous heavy-
atom contribution only (HAanom) for density modification
wherever possible, as these consistently produced superior
density-modified maps. Map quality was judged initially by
visual inspection and quantified by calculating the correlation
coefficient with the final refined 2mFo  DFc map using
PHENIX (Adams et al., 2011). Of the density-modification
programs tested, Parrot (Zhang et al., 1997; Cowtan, 2010)
delivered the best maps, which could be further improved
slightly by using PDB entry 4zgf (Joint Center for Structural
Genomics, unpublished work) as a reference data set for
histogram matching rather than the default PDB entry 1tqw
(Kuntz et al., 2005).
2.4. Model refinement and validation
An initial model derived from PDB entry 1exr with all
amino-acid side chains in a single conformation was used to
build the Ca2+-SeMet CaM model. 1exr was used instead of an
automatically built model because autobuilding struggled with
the weak density of the central helix region, resulting in
fragmented models with the two domains separated. Adjust-
ments to the model, including the introduction of ordered
solvent molecules and alternate amino-acid conformations,
were made in Coot (Emsley & Cowtan, 2004) with reference
to density-modified experimentally phased 2mFo  DFc and
mFo  DFc maps. Cycles of model building and adjustment
were alternated with conjugate-gradient least-squares refine-
ment in SHELX against an intensity-based residual target
function with geometric (DFIX, DANG, FLAT), ADP
(DELU, SIMU) and occupancy (PART) restraints (Sheldrick,
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Table 1
Data collection and processing.
Values in parentheses are for the outer shell.






a, b, c (A˚) 25.04, 29.41, 52.79
, ,  () 89.45, 86.29, 82.39
Mosaicity () 0.45
Resolution range (A˚) 25–1.00 (1.02–1.00)
Total No. of reflections 419257
No. of unique reflections 75551
Completeness (%) 94.0 (84.7)
Anomalous completeness (%) 92.6 (78.8)
Multiplicity 5.5 (3.8)




+, I merged) 0.121 (2.19)
Rmeas (I
+, I separate) 0.099 (2.19)
Overall B factor from Wilson plot (A˚2) 8.96
† hI/(I)i decreases to 2.0 at 1.04 A˚ resolution. ‡ CC1/2 (Karplus & Diederichs, 2012)
was used to determine the high-resolution cutoff.
Table 2
Structure solution and refinement.









PDB code 5e1k 5e1n 5e1p
Refinement program SHELX-14 PHENIX 1.9 PHENIX 1.9
Resolution range (A˚) 25–1.00 25–1.00 25–1.00
Completeness (%) 94.0 94.0 97.4
No. of reflections, working set 71779 71737 69345
No. of reflections, test set 3772 3772 7778
Rcryst 0.1436 0.1337 0.1249
Rfree 0.1649 0.1495 0.1424
Rall 0.1440 0.1345 0.1267
No. of non-H atoms
Protein 1636 2942 2607
Ion 5 5 5
Ligand 16 16 16
Water 176 178 180
Total 1833 3141 2808
R.m.s. deviations
Bonds (A˚) 0.013 0.013 0.010
Angles () n.a. 1.489 1.317
Angle (1–3) distances (A˚) 0.0294 n.a. n.a.
Average B factors (A˚2)
Protein 17.5 14.1 13.9
Ion 11.4 10.8 10.3
Ligand 28.2 29.8 21.0
Water 32.3 26.8 25.5
ADP anisotropy†
Protein 0.388 0.432 0.464
Ion 0.414 0.384 0.368
Ligand 0.358 0.578 0.714
Water 0.335 0.479 0.594
Ramachandran plot
Most favored (%) 99.6 99.4 98.7
Allowed (%) 0.4 0.6 0.9
† ADP anisotropy is defined as the ratio of the smallest to the largest eigenvalue of the
anisotropic ADP tensor.
2008). Friedel-merged intensities were used. Anisotropic
ADPs were introduced into the model after convergence of
the isotropic ADP refinement, and riding H atoms were
included except for the O atom of Ser, the OH atom of Tyr
and the N1 atom of His, owing to ambiguities in their idea-
lized position or residue ionization state. In the final cycles of
refinement of the converged model, the test set of reflections
that were previously sequestered for the calculation of the
Rfree value (Bru¨nger, 1992) were included in the refinement.
Several close contacts between partially occupied water
molecules and disordered protein atoms were identified
during model building. These clashes occur between atoms
whose occupancies sum to less than unity and are therefore
examples of correlated disorder. In order to prevent these
regions being incorrectly flagged as van der Waals contact
violations, we assigned altloc IDs to the disordered water
molecules in the final models.
In order to facilitate direct comparison between the
SHELXL-refined model and the PHENIX-refined
qFit2.0 models (see below), we used the program
phenix.model_vs_data to calculate the R and Rfree values for
the SHELXL model using the bulk-solvent and anisotropic
scaling routines implemented in PHENIX (Afonine et al.,
2010). These values are Rfree = 15.6%, R = 13.4% and should
be compared with the values reported in Table 2. The model
was validated using Coot (Emsley & Cowtan, 2004) and
MolProbity (Chen et al., 2010) and the anisotropic ADPs were
analysed using PARVATI (Zucker et al., 2010). Refined model
statistics are shown in Table 2. Structural figures were
produced with POVScript+ (Fenn et al., 2003).
Automated detection and modeling of alternative side-
chain and backbone conformations was performed using
qFit2.0 (Keedy et al., 2015). Structure-factor amplitudes and
refined single-conformer models were used to calculate
2mFo  DFc and mFo  DFc maps. For the Ca2+-CaM qFit2.0
model (PDB entry 5e1p), the diffraction data were those
deposited with the original PDB code 1exr. Electron density
was sampled using standard rotamer libraries for all residues
that had anisotropic electron density at side-chain or back-
bone atoms indicative of a potentially disordered residue. One
to four conformations were chosen for each amino acid and
the resulting models were refined in PHENIX with anisotropic
ADPs and riding H atoms against an Friedel-merged
amplitude-based maximum-likelihood target with geometric
and ADP restraints (Afonine et al., 2012). The ADP and
geometric weights were optimized and the occupancies of
alternative conformations were refined but constrained to sum
to unity. Model statistics are shown in Table 2.
Anisotropic ADP validation was performed using
PARVATI (Zucker et al., 2010) and ANISOANL (Winn,
2001). The anisotropies of the qFit models refined using
PHENIX are systematically higher (indicative of more
isotropic character of the ADPs) than those refined against
the same data in SHELX (Table 2). This disparity reflects
differences in the type and application of anisotropic ADP
restraints in these two programs.
3. Results
3.1. SAD phasing and density modification
Experimental phases were obtained using single-wavelength
anomalous diffraction (SAD) near the Se K edge of Ca2+-
SeMet CaM crystals. CaM has eight methionines (excluding
the N-terminal Met), resulting in the incorporation of eight
anomalous scatterers in 148 amino acids. In addition, the five
bound Ca2+ ions also have a weak anomalous signal (0.58 e)
at this wavelength. The absence of point-group symmetry in
these crystals poses particular challenges for anomalous data
collection, including balancing the requirements for reason-
able data completeness and multiplicity with the need to
minimize radiation damage to the sample. Consequently, a
SAD data set was collected because a two-wavelength MAD
data collection would inflict unacceptable radiation damage
research papers
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Figure 1
Anomalous signal in the Ca2+-SeMet CaM Se SAD data set. In (a), the
correlation coefficient for anomalous differences over random halves of
the data (CCanom; orange circles) and the correlation coefficient for
intensities over random halves of the data (CC1/2; blue squares) are
shown as a function of resolution. The dashed line shows the CCanom
cutoff of 0.3 (1.33 A˚ resolution) and the dotted line shows a less
conservative cutoff of 0.15 (1.23 A˚ resolution). In (b), the extent of
anomalous signal is plotted as the ratio of the anomalous difference signal
to noise (red circles) and anomalous measurability (blue squares). All
three estimates suggest that there is measurable anomalous signal to
1.3 A˚ resolution in this data set.
on the sample. Furthermore, the completeness is lower than
desired in the highest resolution bin (85%; Table 1) owing to
complications arising from the blind cone in space group P1 at
high resolution. Although the sample was reoriented in order
to capture some of the blind-cone data, the range of this
reorientation was limited by the beamline geometry.
The SeMet SAD data set contains significant anomalous
signal to approximately 1.33 A˚ resolution based on the
anomalous correlation coefficient between random halves of
the unmerged data (CCanom = 0.3) as calculated by AIMLESS
(Evans & Murshudov, 2013; Fig. 1a). Some anomalous signal
may extend as far as 1.23 A˚ resolution if a less conservative
cutoff of CCanom = 0.15 is used. As additional measures of
anomalous data quality, the mean anomalous signal-to-noise
[hI/(I)i, where I is the Bijvoet difference I+  I] and
anomalous measurability (Zwart, 2005) also indicate that
anomalous signal is present to 1.3 A˚ resolution (Fig. 1b) using
cutoffs of 1.2 and 0.05, respectively. Despite challenges arising
from the low symmetry of this triclinic crystal, the anomalous
data have an overall completeness of 93% and a multiplicity of
2.8 (Table 1). These values are likely to represent upper limits
attainable from this sample, as more extensive exposure of
similar crystals to X-rays resulted in an obvious loss of high-
resolution reflections. SAD phasing performed using Phaser
(Read & McCoy, 2011) gives a final figure of merit of 0.44,
which indicates good starting SAD phase-angle estimates.
As SAD phase probability distributions are bimodal, phase
improvement by density modification was necessary to obtain
optimal electron-density maps, although the SAD-phased
maps were clearly interpretable without modification. Density
modification was performed with default settings as imple-
mented in several current software packages (see x2). While
all produced excellent maps, the best-performing program was
Parrot (Zhang et al., 1997; Cowtan, 2010), which produced an
electron-density map (Fig. 2) that was comparable to others in
well ordered regions but showed clearer electron density for
many disordered or partially occupied residues. We suspected
that the superior performance of Parrot may be owing in part
to its default use of the high-resolution (1.2 A˚) reference
structure 1tqw for histogram matching. This atomic resolution
reference structure should more closely resemble the expected
features of the electron density of Ca2+-SeMet CaM at 1.0 A˚
resolution than would the default settings in other programs.
In order to optimally match reference and target electron
density, we selected PDB entry 4zgf as a new reference for
histogram matching. The 1.0 A˚ resolution 4zgf structure (Joint
Center for Structural Genomics, unpublished work) contains
both selenomethionine and Ca2+ and thus closely matched
the atomic composition and data-set resolution of Ca2+-SeMet
CaM. The resulting Parrot density-modified map had a
correlation coefficient (CC) of 0.88 with the final 2mFo  DFc
electron density, a CC of 0.77 with the final refined Ca2+-
SeMet CaM model and was slightly better by visual inspection
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Figure 2
A view of the density-modified SAD electron density around the second
Ca2+ site. Parrot-modified, SAD-phased experimental electron density is
shown at 1.0 (orange) and 4.0 (magenta) for an EF-hand Ca2+-binding
site (site II). The map contoured at 4.0 shows separation of atomic
electron density for Glu67 and other residues.
Figure 3
Location of disordered residues and bound MPD in Ca2+-SeMet CaM.
The locations of modeled disordered residues (yellow spheres) and of
bound MPD are shown on a ribbon diagram of the SHELXL-refined
model of Ca2+-SeMet CaM (blue). N- and C-termini are labeled.
than the map obtained using PDB entry 1tqw as a reference.
Overall, the Parrot 2mFo  DFc map CC was 0.05–0.1 higher
than those obtained using maps calculated with other density-
modification programs. The sensitivity of the final electron-
density map to the particular density-modification algorithm
employed indicates that this Ca2+-SeMet CaM SAD data set
could be useful for the testing and improvement of density-
modification approaches at atomic resolution.
3.2. Modeling conformational disorder and comparison with
1exr
As expected, the final refined Ca2+-SeMet CaM model is
nearly identical to the previously refined 1.0 A˚ resolution
crystal structure (PDB entry 1exr; Wilson & Brunger, 2000),
with a C r.m.s.d. of 0.1 A˚. The protein adopts the same
extended, dumbbell-shaped conformation as seen in all other
triclinic Ca2+-CaM structures (Fig. 3). As in PDB entry 1exr,
there is a fifth Ca2+ ion that mediates a lattice contact between
Glu47 and Asp58 of a neighboring molecule.
Ca2+-CaM is one of the premier examples of physiologically
relevant protein conformational dynamics. Consequently,
crystalline Ca2+-CaM is more extensively disordered than
most proteins that diffract to atomic resolution. We previously
modeled 37 disordered residues in the structural model of
Ca2+-CaM (PDB entry 1exr) using conservative criteria that
excluded many ambiguously disordered residues (Wilson &
Brunger, 2000). For the Ca2+-SeMet CaM model, we relaxed
these criteria and manually built a total of 57 residues into
alternate conformations, which represents 39% of the protein
(Fig. 3). The larger number of alternate conformations in
Ca2+-SeMet CaM is solely a consequence of this less conser-
vative approach to identifying disordered residues, as the final
2mFo  DFc electron-density maps for this structure and the
prior 1.0 A˚ resolution Ca2+-CaM structure are quite similar,
with a CC of 0.94. In addition, the disordered residues
common to both 1exr and Ca2+-SeMet CaM are similarly
modeled, despite the fact that the disorder model in 1exr was
not used as a reference or a starting point for the Ca2+-SeMet
CaM model. Moreover, the degree of overall atomic disorder
between the two models is also similar, with an average ADP
for all protein atoms of 17.4 A˚2 and an average protein ADP
anisotropy of 0.388 for Ca2+-SeMet CaM, which is comparable
to the average protein ADP of 16.4 A˚2 and protein ADP
anisotropy of 0.353 previously reported for 1exr. The consis-
tencies between 1exr and our new model suggest functional
conformational disorder, rather then idiosyncrasies resulting
from cryocooling (Keedy et al., 2014). Therefore, the increased
number of modeled disordered residues in Ca2+-SeMet CaM
represents an improved model of conformational disorder
compared with the conservative approach taken with 1exr.
As an objective measure of the degree of conformational
disorder in these two proteins, qFit2.0 was used for automated
alternate main-chain and side-chain conformation modeling
based on 2mFo  DFc electron density (Keedy et al., 2015).
qFit2.0 identifies 138 disordered residues in Ca2+-CaM (data
from PDB entry 1exr) and 137 residues in Ca2+-SeMet CaM,
indicating that these two proteins are similarly disordered.
The exceptionally high percentage of disordered residues
identified by qFit2.0 (93%) is consistent with the highly flex-
ible nature of Ca2+-CaM, although some overestimation of
disorder is also possible, as an earlier implementation of qFit
had an estimated false-discovery rate of 5–10% (van den
Bedem et al., 2009).
Given the large number of disordered residues, it is
unsurprising that a significant fraction are difficult to model.
Experimental phase information has been shown to improve
the identification and modeling of conformational disorder in
other systems (Burling et al., 1996; Brodersen et al., 2000) and
shows similar benefit in this system. An example is Arg94,
which was identified as disordered in both the manually built
and qFit2.0 models. The manual model features two confor-
mations, but three conformations were identified by
qFit2.0 based on automated sampling of the model-phased
2mFo  DFc electron density. The third qFit2.0 alternate
research papers
88 Lin et al.  Ca2+-calmodulin Acta Cryst. (2016). D72, 83–92
Figure 4
Experimental phase information clarifies cases of ambiguous discrete
disorder. In all panels, Parrot-modified, SAD-phased electron density at
0.9 is shown in orange and final 2mFo  DFc electron density at 0.9
is shown in blue. The darker-colored atoms are the manually built
disordered model and the residues in lighter grey are those automatically
built by qFit2.0. Arg94 (a), Glu14 (b), Val108 (c) and Glu123 (d) all show
clearer evidence of discrete disorder in the experimental electron-density
map than in the 2mFo  DFc map at this contour level.
side-chain conformation, a rotamer about the 1 angle, is not
visible in 2mFo  DFc electron density contoured at 0.9–0.7
and was therefore missed by manual building into the same
maps. However, inspection of the density-modified SAD-
phased maps at 0.9 shows electron density supporting the
third conformation (Fig. 4a). Importantly, qFit2.0 was able to
accurately model the disorder at Arg94 using only model
phases, but the inclusion of less biased experimental phase
information in the density-modified maps makes this case of
disorder easier to identify and confidently model. 2mFoDFc
electron density supporting the third conformation of Arg94
becomes visible at 0.5, which
is below the contour level that
most crystallographers typically
use for model construction.
The utility of such low-contour
electron-density map features in
characterizing protein conforma-
tional heterogeneity has recently
been demonstrated (Lang et al.,
2010, 2014; Fraser et al., 2009).
Additional examples where
experimental phase information
supports qFit2.0 modeling of
side-chain disorder in low-
contour electron-density features
are Glu14, Val108 and Glu123
(Figs. 4b, 4c and 4d).
3.3. Previously unexplained
electron-density features are
consistent with MPD bound to
Ca2+-CaM in multiple locations
Inspection of the density-
modified SAD-phased electron
density revealed strong evidence
for two molecules of MPD: one
mediates a lattice contact invol-
ving helices I and III of the
N-terminal domain and the other
is located in the C-terminal
hydrophobic binding pocket
(Figs. 3, 5a and 5b). Both of
these areas contained residual
mFo  DFc electron density in
the prior structure of Ca2+-CaM
(PDB entry 1exr) suggestive of
an unidentified bound species.
Because this density was weak
and thus their assignment was
ambiguous, these features were
conservatively but incorrectly
modeled as water. In this new
structure, the density-modified
experimental electron density for
these MPD molecules is highly
consistent with the final 2Fo  DFc map, enhancing
the confidence that these two MPD molecules are correctly
assigned and minimally influenced by model bias, which can be
especially pernicious when modeling partially occupied or
otherwise disordered ligands (Pozharski et al., 2013).
Both MPD molecules are bound in regions that bias the two
domains of Ca2+-CaM towards more open EF-hand confor-
mations (Fig. 3), likely contributing to the discrepancy
between the crystal structure and the more closed solution
structure of Ca2+-CaM (Chou et al., 2001; Wilson & Brunger,
2000). For the N-terminal MPD mediating the lattice contact
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Figure 5
MPD binds to Ca2+-CaM at multiple locations and overlaps with a critical target-binding site. (a) shows the
density-modified, SAD-phased electron density contoured at 0.9 (orange) and 2mFo  DFc electron
density at 0.9 (blue) around the MPD-binding site in the C-terminal hydrophobic binding pocket.
Surrounding residues are labeled. (b) shows the MPD bound at the N-terminal lattice contact between
residues in helix I (black lines) and helix III (background, light gray lines). In both panels, the experimental
electron density unambiguously supports a bound MPD molecule. In (c) mFo  DFc electron density at
3.0 (green, red) is shown with the density-modified map contoured at 0.9 (orange) for a potential MPD
site in the N-terminal domain. The disordered MPD molecule (gray lines) is broadly consistent with this
density feature but was not included in the final model. In (d) the C-terminal lobe of the crystal structure of
Ca2+-CaM bound to a peptide from smooth muscle myosin light-chain kinase (smMLCK; PDB entry 1cdl)
is shown in ribbon representation, with the peptide in green and CaM in yellow. The C-terminal domain of
Ca2+-SeMet CaM (blue) is superimposed, with MPD rendered as sticks. The MPD site overlaps closely with
the position of the indole side chain of Trp800 in the smMLCK peptide.
between helices I and III, these intermolecular interactions
would not be possible if these helices were shifted into the
more closed conformation observed in solution (PDB entry
1j7o; Chou et al., 2001) owing to steric conflicts between
multiple residues. In particular, the 26 shift of helix I
observed in the solution structure would place Glu14 into
conflict with MPD and also disrupt other lattice contacts.
Although it is impossible to formally separate the contribu-
tions of crystal lattice contacts and MPD binding to the more
open conformation of the crystalline N-terminal lobe, we can
conclude that MPD could not reside at this location if the
more closed solution structure had been crystallized. A similar
steric conflict is observed with MPD bound in the C-terminal
hydrophobic pocket, where the shifted helix VIII in the
solution structure (PDB entry 1j7p) would place residues
Met144 and Met145 into steric conflict with the bound MPD.
Therefore, binding of MPD both favors more open confor-
mations of the two domains and facilitates triclinic lattice
formation.
MPD has a chiral center at the C4 atom (secondary alcohol
position) and racemic MPD was used as a precipitant to grow
these crystals. Both molecules of bound MPD were modeled in
their 4S configuration, which is consistent with the electron
density. We cannot rule out, however, that both enantiomers
might be present at both bound MPD sites. The electron
density for MPD bound in the C-terminal pocket of Ca2+-
SeMet CaM could support either enantiomer reasonably well,
as the density corresponding to the C5 atom of S-MPD is weak
and could also agree with the O4 atom of R-MPD. The
environment of this atom is hydrophobic and thus is less
consistent with an O atom (in R-MPD) than with a C atom
(in S-MPD), leading to the tentative assignment of S-MPD.
We note that the C5 atom has the highest ADPs and lowest
electron density of any atom in both MPD molecules,
consistent with possible averaging over MPD enantiomers.
While the C-terminal hydrophobic pocket contains a clear
MPD molecule, there is ambiguous but significant (3–6)
mFo  DFc electron density in the N-terminal pocket that
overlaps partially with a feature in the density-modified SAD
map (Fig. 5c). Although this electron density is difficult to
definitely assign and was left unmodeled in the final structure,
it is consistent with a disordered MPD molecule (Fig. 5c).
These two conformations make chemically plausible contacts
with surrounding residues and are in a highly hydrophobic
local environment that would be expected to interact with less
polar components of the mother liquor such as MPD.
3.4. MPD binds in a critical region of the C-terminal pocket
and is correlated with side-chain disorder
The presence of bound MPD in the C-terminal binding
pocket is intriguing since Ca2+-CaM uses these surfaces to
bind its many targets. One of the best-characterized examples
is the complex between Ca2+-CaM and a peptide derived from
smooth muscle myosin light-chain kinase (smMLCK; PDB
entry 1cdl; Meador et al., 1992). Superimposing the structure
of Ca2+-CaM–smMLCK with Ca2+-SeMet CaM shows that the
MPD in the C-terminal binding pocket overlaps with Trp800
from smMLCK (Fig. 5d). Trp800 penetrates deeply into the
hydrophobic binding pockets of Ca2+-CaM and is a critical
binding determinant for the interaction with smMLCK
(Meador et al., 1992; Bagchi et al., 1992). Because this site
would be partially occluded in the more closed conformations
of the EF hands, bound MPD molecules are likely to bias the
C-terminal (and possibly N-terminal) domains towards more
open, target complex-like conformations in the triclinic crystal
structure of Ca2+-CaM.
The C-terminal lobe MPD molecule was refined to an
occupancy of 0.52, which is similar to the refined occupancy of
the nearer of the two alternate conformations of Ile136. This
similarity is significant because the C1 atom of the minor
second conformation of Ile136 would clash (2.6 A˚ C–C atom
separation) with the CM atom of MPD if both were fully
occupied (Fig. 6). This provides an unequivocal example of
side-chain disorder coupled to MPD binding, which imposes a
correlation between protein conformational fluctuations and
the occupancy of this binding pocket. Although not the only
example of spatially correlated disorder in Ca2+-CaM, the
adventitiously bound MPD clearly illustrates the importance
of Ca2+-CaM conformational heterogeneity for binding to the
hydrophobic pockets.
4. Discussion
The 1.0 A˚ resolution Ca2+-SeMet CaM SAD data set repre-
sents one of the higher resolution examples of experimental
phase information in the PDB. Because bimodal SAD phase
probability distributions require improvement by density
modification before optimal maps are obtained, this high-
resolution SAD data set provides a potentially useful resource
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Figure 6
Binding of MPD in the C-terminal pocket is correlated with side-chain
disorder at Ile136. The density-modified map contoured at 0.9 (orange)
is shown with the C-terminal MPD molecule and its nearby residue
Ile136. Ile136 samples two conformations (black and gray) and one (gray,
conformer b) sterically conflicts with the bound MPD as shown by the
dashed line.
for optimizing the performance of density-modification algo-
rithms at atomic resolution. Our results show that Parrot
was the best-performing algorithm tested, although we used
default parameters for the tested programs and thus cannot
rule out the possibility that other programs may perform
better with different parameterization. Although the quality
of all density-modified maps was comparable in well ordered
regions, Parrot-calculated maps showed stronger and more
easily interpreted density for disordered residues, which are of
particular interest in this system. Experimental phase infor-
mation is highly valuable when used to clarify these weak
electron-density features, as experimentally phased maps are
not subject to phase bias introduced from a structural model
and thus can be used to critically evaluate the placement of
alternative side-chain conformations and ligands into ambig-
uous electron density. We note that density modification
represents the deliberate introduction of particular forms of
phase bias into the map; however, this bias does not favor a
particular structural model and is thus less problematic than
traditional sources of model phase bias when interpreting
difficult regions of electron density.
The value of experimental phase information for char-
acterizing conformational heterogeneity has been recognized
for some time (Brodersen et al., 2000; Burling et al., 1996). This
analysis of Ca2+-SeMet CaM confirms and extends a prior
characterization of the extensive side-chain disorder present
in crystalline Ca2+-CaM based on model phases (Wilson &
Brunger, 2000). Although much of the modeled disorder in
PDB entry 1exr is supported by this new Ca2+-SeMet CaM
structure, less stringent criteria for introducing alternative
conformations as well as the availability of experimental phase
information allows a significant expansion of the disordered
model. The manually built Ca2+-SeMet CaM model contains
39% of the residues in alternate conformations, while the
automated disorder-modeling approach implemented in
qFit2.0 indicates that 93% of the residues sample multiple
conformations. Considered in the light of recent results from
diverse proteins (Deis et al., 2014; Fraser et al., 2009, 2011;
Keedy et al., 2014; Lang et al., 2010, 2014), there is compelling
evidence that crystalline proteins are more extensively disor-
dered than previously thought and that traditional criteria for
modeling disorder are probably too conservative. Being free
of model bias, experimental phase information could aid in the
development of new criteria for the detection and modeling of
protein conformational disorder. Because experimental
phases are observations and thus increase the observation-to-
parameter ratio in refinement, they may be fruitfully used in
ensemble-refinement approaches, where they could mitigate
concerns about potential overfitting of the data (Burnley et al.,
2012; Burling & Bru¨nger, 1994), although we did not explore
this application here. Moreover, experimental phase infor-
mation would be a particularly powerful way to characterize
conformational heterogeneity when obtained from crystals at
room temperature.
These SeMet Ca2+-CaM SAD data have resolved a long-
standing question about the proper assignment of ambiguous
electron-density features in both hydrophobic binding pockets
of Ca2+-CaM, which we have shown to be MPD. The
observation of bound MPD at multiple locations helps explain
why the EF-hands of Ca2+-CaM are more open in triclinic
crystal structures than in solution, as MPD binds in a target-
like fashion to at least the C-terminal binding pocket and
probably the N-terminal pocket as well. In addition, an MPD
molecule mediates a lattice contact that bridges helices I and
III of neighboring N-terminal lobes, stabilizing more open
conformations of this domain. Ca2+-CaM is a difficult protein
to crystallize, and nearly all prior structures have used MPD as
a precipitant. Even in CaM structures determined in different
space groups, electron-density features suggestive of bound
MPD are present (Wilson & Brunger, 2003). Interestingly,
one structure of Ca2+-CaM that used PEG rather than MPD
as a precipitant (PDB entry 1prw) shows the molecule in a
dramatically different, partially closed conformation (Fallon &
Quiocho, 2003). Furthermore, a structure of the Ca2+-CaM
N-terminal domain alone (PDB entry 3ikf) obtained using
PEG as a precipitant shows residues from the central linker
region bound in the N-terminal pocket of neighboring mole-
cules, similar to the location of bound MPD in the triclinic
structure (O’Donnell et al., 2009). Therefore, we propose that
MPD acts as both ligand and precipitant in many crystal
structures of Ca2+-CaM, and that the presence of MPD as an
adventitious CaM ligand needs to be incorporated into future
interpretations of this well known structure.
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